Dr. O'Dea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Shawnee Mission Pkwy
Ste 1102
Westwood, KS 66205Phone+1 913-588-7791Fax+1 913-588-3648
Education & Training
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of Kansas School of MedicineResidency, Internal Medicine, 2004 - 2007
- University of Kansas School of MedicineClass of 2004
Certifications & Licensure
- KS State Medical License 2007 - 2025
- MO State Medical License 2021 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression Start of enrollment: 2009 Jul 01
Publications & Presentations
PubMed
- 47 citationsRandomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang
Clinical Cancer Research. 2021-02-15 - 34 citationsClinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancerPriyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid A. Mayer
Clinical Cancer Research. 2021-02-18 - 44 citationsA Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh
Clinical Cancer Research. 2021-10-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: